Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class ASSE: 600513

Announcement on Adding Extraordinary Proposal to the 4th Extraordinary General Meeting in 2025

· Issued by Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Adding Extraordinary Proposal to the 4th Extraordinary General Meeting in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment